Stoke Therapeutics STOK
NASDAQ STOK
$26.23 +0.23 (+0.88%)
As of: Oct 1, 2026 · 10:15 AM EDT

Stoke Therapeutics (STOK) Interest Expenses (2025 - 2026)

Updated

Stoke Therapeutics (STOK) reported Interest Expenses of $17,000 for Q2 2026, up 466.7% from $3,000 a year earlier but down 26.1% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Interest Expenses (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Stoke Therapeutics' Interest Expenses came in at $44,000.

  • Five-year quarterly Interest Expenses spans a low of $1,000 in Q1 2025 and a high of $23,000 in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Stoke Therapeutics 1.62 Bn 453.12 Mn - 17,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17,000.00
Mar 31, 2026 23,000.00
Jun 30, 2025 3,000.00
Mar 31, 2025 1,000.00
API Access

Stoke Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=STOK&period=max&api_key=YOUR_API_KEY